These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12067907)

  • 1. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression.
    Lutgens E; Gijbels M; Smook M; Heeringa P; Gotwals P; Koteliansky VE; Daemen MJ
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):975-82. PubMed ID: 12067907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques.
    Cipollone F; Fazia M; Mincione G; Iezzi A; Pini B; Cuccurullo C; Ucchino S; Spigonardo F; Di Nisio M; Cuccurullo F; Mezzetti A; Porreca E
    Stroke; 2004 Oct; 35(10):2253-7. PubMed ID: 15297631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta: a local or systemic mediator of plaque stability?
    Lutgens E; Daemen MJ
    Circ Res; 2001 Nov; 89(10):853-5. PubMed ID: 11701610
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.
    Mallat Z; Gojova A; Marchiol-Fournigault C; Esposito B; Kamaté C; Merval R; Fradelizi D; Tedgui A
    Circ Res; 2001 Nov; 89(10):930-4. PubMed ID: 11701621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.
    Muraoka RS; Dumont N; Ritter CA; Dugger TC; Brantley DM; Chen J; Easterly E; Roebuck LR; Ryan S; Gotwals PJ; Koteliansky V; Arteaga CL
    J Clin Invest; 2002 Jun; 109(12):1551-9. PubMed ID: 12070302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discoidin Domain Receptor-1 Regulates Calcific Extracellular Vesicle Release in Vascular Smooth Muscle Cell Fibrocalcific Response via Transforming Growth Factor-β Signaling.
    Krohn JB; Hutcheson JD; Martínez-Martínez E; Irvin WS; Bouten CV; Bertazzo S; Bendeck MP; Aikawa E
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):525-33. PubMed ID: 26800565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension.
    Yung LM; Nikolic I; Paskin-Flerlage SD; Pearsall RS; Kumar R; Yu PB
    Am J Respir Crit Care Med; 2016 Nov; 194(9):1140-1151. PubMed ID: 27115515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant soluble transforming growth factor beta type II receptor ameliorates radiation enteropathy in mice.
    Zheng H; Wang J; Koteliansky VE; Gotwals PJ; Hauer-Jensen M
    Gastroenterology; 2000 Nov; 119(5):1286-96. PubMed ID: 11054386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury.
    Ruocco A; Nicole O; Docagne F; Ali C; Chazalviel L; Komesli S; Yablonsky F; Roussel S; MacKenzie ET; Vivien D; Buisson A
    J Cereb Blood Flow Metab; 1999 Dec; 19(12):1345-53. PubMed ID: 10598939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth.
    Smith JD; Bryant SR; Couper LL; Vary CP; Gotwals PJ; Koteliansky VE; Lindner V
    Circ Res; 1999 May; 84(10):1212-22. PubMed ID: 10347096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development.
    Bobik A; Agrotis A; Kanellakis P; Dilley R; Krushinsky A; Smirnov V; Tararak E; Condron M; Kostolias G
    Circulation; 1999 Jun; 99(22):2883-91. PubMed ID: 10359732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of cyclosporine a nephrotoxicity in vivo by transforming growth factor beta receptor-immunoglobulin G chimeric protein.
    Xin J; Homma T; Matsusaka T; Ma J; Isaka Y; Imai E; Ichikawa I
    Transplantation; 2004 May; 77(9):1433-42. PubMed ID: 15167603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice.
    Van Herck JL; Schrijvers DM; De Meyer GR; Martinet W; Van Hove CE; Bult H; Vrints CJ; Herman AG
    J Vasc Res; 2010; 47(3):231-40. PubMed ID: 19893320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance.
    McCaffrey TA; Du B; Fu C; Bray PJ; Sanborn TA; Deutsch E; Tarazona N; Shaknovitch A; Newman G; Patterson C; Bush HL
    J Mol Cell Cardiol; 1999 Sep; 31(9):1627-42. PubMed ID: 10471347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice.
    Brånén L; Hovgaard L; Nitulescu M; Bengtsson E; Nilsson J; Jovinge S
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2137-42. PubMed ID: 15345516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism.
    Van Aarsen LA; Leone DR; Ho S; Dolinski BM; McCoon PE; LePage DJ; Kelly R; Heaney G; Rayhorn P; Reid C; Simon KJ; Horan GS; Tao N; Gardner HA; Skelly MM; Gown AM; Thomas GJ; Weinreb PH; Fawell SE; Violette SM
    Cancer Res; 2008 Jan; 68(2):561-70. PubMed ID: 18199553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice.
    Gojova A; Brun V; Esposito B; Cottrez F; Gourdy P; Ardouin P; Tedgui A; Mallat Z; Groux H
    Blood; 2003 Dec; 102(12):4052-8. PubMed ID: 12920022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques.
    Harmon EY; Fronhofer V; Keller RS; Feustel PJ; Zhu X; Xu H; Avram D; Jones DM; Nagarajan S; Lennartz MR
    J Am Heart Assoc; 2014 Dec; 3(6):e001232. PubMed ID: 25516435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis.
    Bonniaud P; Margetts PJ; Ask K; Flanders K; Gauldie J; Kolb M
    J Immunol; 2005 Oct; 175(8):5390-5. PubMed ID: 16210645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.
    Swallow CJ; Partridge EA; Macmillan JC; Tajirian T; DiGuglielmo GM; Hay K; Szweras M; Jahnen-Dechent W; Wrana JL; Redston M; Gallinger S; Dennis JW
    Cancer Res; 2004 Sep; 64(18):6402-9. PubMed ID: 15374947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.